As global markets experience shifts, with small-cap indices like the Russell 2000 and S&P MidCap 400 outperforming, investors ...

Completes Transition to Immune-Mediated Disease Focused CompanyHighlights Additional Data from Phase 1b Primary Membranous ...

A research team from Germany and the U.S. led by Heinrich Heine University Düsseldorf (HHU) has developed a data description ...

A study finds Google's AI overviews provide misleading or inaccurate information in 43% of finance-related searches.

Soft-tissue repair company Aroa Biosurgery is up ~12% today after reporting its quarterly update with a strong increase in ...

While Judo Bio was preparing for its public launch, so was another siRNA start-up. City Therapeutics, the latest project of ...

Sarfaraz K. Niazi, PhD, provides an overview of the current biosimilar education material offered by the FDA, emphasizing ...

An investigational dual-action inhibitor for geographic atrophy (GA) significantly slowed disease progression and improved ...

As global markets navigate a complex landscape marked by interest rate adjustments and sector-specific shifts, the U.S. indices have shown resilience with notable performances in mid-cap and small-cap ...

Researchers have unveiled a novel approach to tackle obesity by targeting fat absorption in the small intestine. The cutting-edge nanoparticle system, engineered to deliver therapeutic molecules ...

Previously, he served as the editor of iGeeksBlog and is a self-proclaimed tech enthusiast who loves breaking down complex information for a broader audience. Instagram's new tools educate users ...

This technology quickly and sensitively detects metabolites and changes in cancer patients' body fluids, providing a ...